News
Lilly buys into psychedelics with $3.8bn AtaiBeckley deal
AtaiBeckley has been snapped up by Eli Lilly in a massive $3.8bn transaction that shows psychedelic drugs are now firmly in the pharma mainstream.
Monday 5 October 2026
